A new international study led by Mayo Clinic researchers has identified a genetic factor that may explain why some patients ...

Patients who have undergone surgery for colorectal cancer experience fewer serious complications and fewer readmissions when ...

Patients with inflammatory bowel disease had a higher risk for venous thromboembolism after surgery for colorectal cancer than those without IBD, according to a Danish cohort study published in The ...

Researchers found that 160 milligrams of daily aspirin significantly lowered cancer recurrence risk for colorectal patients ...

Low-dose aspirin use was linked to a 55% lower risk of colorectal cancer recurrence in people with a genetic mutation that ...

A low dose reduces the likelihood of recurrence in people who have had surgery to remove tumors with a common genetic ...

Colorectal cancer is the second most common cause of cancer-related death in women and the third most common in men. Since the 1980s, the incidence of colorectal cancer in individuals aged 50 and ...

A new study finds that the common over-the-counter medication Aspirin could significantly cut the risk of colorectal cancer ...

Mayo Clinic researchers have discovered a genetic factor that may explain why some colorectal cancer patients experience ...

Taken together with previous observational, genomic, and early trial data, our findings support the integration of aspirin into clinical practice for a molecularly defined subgroup of patients with ...

Taking daily low-dose aspirin could almost halve the risk of colorectal cancer recurrence for some patients whose tumors have ...